SK279891B6 - Inklúzny komplex n-etoxykarbonyl-3-morfolínosydnon - Google Patents

Inklúzny komplex n-etoxykarbonyl-3-morfolínosydnon Download PDF

Info

Publication number
SK279891B6
SK279891B6 SK851-91A SK85191A SK279891B6 SK 279891 B6 SK279891 B6 SK 279891B6 SK 85191 A SK85191 A SK 85191A SK 279891 B6 SK279891 B6 SK 279891B6
Authority
SK
Slovakia
Prior art keywords
cyclodextrin
ethoxycarbonyl
morpholinosydnonimine
salt
complex
Prior art date
Application number
SK851-91A
Other languages
English (en)
Slovak (sk)
Inventor
M�Ria Vikmon
J�Zsef Szejtli
J�Zsef Ga�L
Istv�N Hermecz
�Gnes Horv�Th
Katalin M�Rmarosi
G�Bor Horv�Th
Ir�N Munk�Csi
Original Assignee
Therabel Industries S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therabel Industries S.A. filed Critical Therabel Industries S.A.
Publication of SK279891B6 publication Critical patent/SK279891B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK851-91A 1990-03-28 1991-03-28 Inklúzny komplex n-etoxykarbonyl-3-morfolínosydnon SK279891B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU901868A HU210921B (en) 1990-03-28 1990-03-28 Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
SK279891B6 true SK279891B6 (sk) 1999-05-07

Family

ID=10956592

Family Applications (1)

Application Number Title Priority Date Filing Date
SK851-91A SK279891B6 (sk) 1990-03-28 1991-03-28 Inklúzny komplex n-etoxykarbonyl-3-morfolínosydnon

Country Status (34)

Country Link
US (1) US5403840A (he)
EP (1) EP0477315B1 (he)
JP (1) JP2582497B2 (he)
KR (1) KR950004705B1 (he)
CN (1) CN1051080C (he)
AT (1) ATE138656T1 (he)
AU (1) AU638824B2 (he)
BG (1) BG61689B1 (he)
BR (1) BR9105136A (he)
CA (1) CA2054188C (he)
CZ (1) CZ287353B6 (he)
DE (1) DE69119853T2 (he)
DK (1) DK0477315T3 (he)
ES (1) ES2090320T3 (he)
FI (1) FI102460B (he)
GE (1) GEP19991832B (he)
GR (1) GR3020684T3 (he)
HR (1) HRP920561B1 (he)
HU (1) HU210921B (he)
IL (1) IL97714A (he)
LT (1) LT3394B (he)
LV (1) LV10245B (he)
MC (1) MC2185A1 (he)
MD (1) MD679G2 (he)
NO (1) NO179611C (he)
OA (1) OA10029A (he)
PL (1) PL165868B1 (he)
RO (1) RO109649B1 (he)
RU (1) RU2111216C1 (he)
SI (1) SI9110908A (he)
SK (1) SK279891B6 (he)
TJ (1) TJ231R3 (he)
UA (1) UA27226C2 (he)
WO (1) WO1991014680A1 (he)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA949182B (en) * 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
GB2290964A (en) * 1994-07-08 1996-01-17 Arto Olavi Urtti Transdermal drug delivery system
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine
ITTO20120056A1 (it) * 2012-01-24 2013-07-25 Borla Ind Connettore per linee medicali di infusione, trasfusione e simili
ITTO20130433A1 (it) * 2013-05-29 2014-11-30 Borla Ind Connettore per linee medicali
BE1028879B1 (fr) 2020-12-11 2022-07-12 Europharmaceuticals Comprimé à libération prolongée de la molsidomine

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1695897C3 (de) * 1966-07-04 1979-02-15 Takeda Chemical Industries Ltd N-Acyl-sydnonimine, deren Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3221425A1 (de) * 1982-06-07 1983-12-08 Boehringer Ingelheim KG, 6507 Ingelheim Hydrolyseempfindlichen wirkstoff enthaltende, lagerstabile tablette
DK243084A (da) 1983-05-26 1984-11-27 Takeda Chemical Industries Ltd Perkutane farmaceutiske praeparater til udvortes brug
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
DE3522191A1 (de) * 1985-06-21 1987-01-15 Cassella Ag Photostabilisierung von sydnoniminen
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
JPH0819004B2 (ja) * 1986-12-26 1996-02-28 日清製粉株式会社 徐放性医薬製剤
IT1204725B (it) * 1987-06-17 1989-03-10 Edmond Pharma Srl Complessi di inclusione del dipiridamolo con ciclodestrine
DE68901043D1 (de) * 1988-01-14 1992-04-30 Akzo Nv Waessriges pharmazeutisches praeparat.
US5120732A (en) * 1988-06-14 1992-06-09 Cassella Aktiengesellschaft Substituted 3-aminosyndone imines, a process for their preparation and their use
IT1227626B (it) * 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
HU211648A9 (en) * 1990-03-28 1995-12-28 Chinoin Gyogyszer Es Vegyeszet Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
CA2054188A1 (en) 1991-09-29
NO179611B (no) 1996-08-05
KR950004705B1 (ko) 1995-05-04
ES2090320T3 (es) 1996-10-16
HRP920561A2 (hr) 1994-04-30
CS85191A3 (en) 1991-11-12
HRP920561B1 (en) 1999-12-31
IL97714A0 (en) 1992-06-21
LTIP386A (en) 1994-12-27
NO914649L (no) 1991-11-27
CN1056688A (zh) 1991-12-04
HUT58109A (en) 1992-01-28
LV10245B (en) 1995-08-20
MD679F1 (en) 1997-02-28
PL165868B1 (pl) 1995-02-28
KR920701182A (ko) 1992-08-11
AU638824B2 (en) 1993-07-08
FI915569A0 (fi) 1991-11-26
JPH04506362A (ja) 1992-11-05
CA2054188C (en) 1996-07-23
UA27226C2 (uk) 2000-08-15
OA10029A (en) 1996-10-14
US5403840A (en) 1995-04-04
HU901868D0 (en) 1990-08-28
WO1991014680A1 (en) 1991-10-03
EP0477315A1 (en) 1992-04-01
JP2582497B2 (ja) 1997-02-19
RU2111216C1 (ru) 1998-05-20
FI102460B1 (fi) 1998-12-15
MD679G2 (ro) 1997-11-30
DK0477315T3 (da) 1996-09-30
DE69119853D1 (de) 1996-07-04
AU7574591A (en) 1991-10-21
TJ231R3 (en) 1999-11-24
NO179611C (no) 1996-11-13
CZ287353B6 (cs) 2000-11-15
ATE138656T1 (de) 1996-06-15
SI9110908A (sl) 1998-06-30
MC2185A1 (fr) 1992-09-16
EP0477315B1 (en) 1996-05-29
CN1051080C (zh) 2000-04-05
IL97714A (he) 1995-03-30
GR3020684T3 (en) 1996-10-31
GEP19991832B (en) 1999-11-05
DE69119853T2 (de) 1996-10-10
FI102460B (fi) 1998-12-15
RO109649B1 (ro) 1995-04-28
LV10245A (lv) 1994-10-20
HU210921B (en) 1995-09-28
LT3394B (en) 1995-09-25
NO914649D0 (no) 1991-11-27
PL293022A1 (en) 1992-12-28
BG61689B1 (bg) 1998-03-31
BR9105136A (pt) 1992-08-04
BG95531A (bg) 1993-12-24

Similar Documents

Publication Publication Date Title
US5244881A (en) Compositions based on imipyramine
EA011275B1 (ru) Суточная дозированная единица комплекса этинилэстрадиол-циклодекстрин
EP3437637A1 (en) Pharmaceutical preparation of palbociclib and preparation method thereof
JPH0819004B2 (ja) 徐放性医薬製剤
US10813937B2 (en) Pharmaceutical formulation of palbociclib and a preparation method thereof
HU183430B (en) Process for producing cyclodextrine inclusion complexes of n-bracket-1-phenylethyl-bracket closed-3,3-diphenylpropylamine or n-bracket-1-phenylethyl-bracket closed-3,3-diphenylpropylamine-hydrochloride
SK279891B6 (sk) Inklúzny komplex n-etoxykarbonyl-3-morfolínosydnon
SK155195A3 (en) Sin- 1a cyclodextrin clathrates
EP0478732B1 (en) Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same
KR960003605B1 (ko) 경구용 오메프라졸 약제의 코어 조성물을 제조하는 방법
KR0135736B1 (ko) 안정한 오메프라졸 레진염
JPH01287094A (ja) ダナゾール−シクロデキストリン包接化合物
HU211906A9 (en) Inclusion complexes of n-ethoxycarbonyl 1-3-morpholino-sydnonimine or salts formed with cyclodextrin-derivatives, preparation thereof and pharmaceutical compositions containing the same
WO2008125134A1 (en) Process for the preparation of perindopril-tert-butylamine adsorbates
SK278809B6 (sk) Inklúzny komplex 3-morfolinosydnonimínu alebo jeho